SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

A sharp rebound is being linked by traders to Intuitive Machines inclusion among companies eligible to compete for NASAs CLPS 2.0 lunar-delivery work, with speculation that future awards could expand its backlog. The reaction is broadly bullish but tempered by debate over whether eligibility means actual contracts, alongside short-squeeze talk and caution ahead of earnings.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

A sharp post-earnings selloff is dominating discussion, with traders focused on slower Amvuttra demand growth and concerns about reimbursement and patient access despite strong product sales. Some see the decline as an overreaction and are buying the dip, while others fault management and worry about continued downside; upcoming cemdisiran and HELIOS-B catalysts are also being watched.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 10.7808229 USD and is down -0.30 over the last 24 hours. It is currently trading on 2314 active market(s) with $147,808,096.15 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

Chainlinks sharp rally and surging volume are driving attention, with traders pointing to CCIP 2.0 and integrations involving tokenized stocks and institutional finance as support for its infrastructure story. Bulls see momentum and adoption building, while skeptics question whether those developments translate into LINK value and warn the move could fade.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

GlobalFoundries is drawing attention after a sharp selloff and a wave of analyst price-target cuts, with traders questioning demand and pricing for its mature-node foundry business as auto and industrial orders soften. Some investors see an earnings and guidance beat as a reason to buy the dip, while others argue it has not eased concerns about utilization, contract renewals, and the stocks weak price action.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,372,680,256.2826 in circulation. The last known price of Stellar is 0.15097866 USD and is down -1.62 over the last 24 hours. It is currently trading on 848 active market(s) with $82,748,701.06 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is drawing attention amid a steep selloff and repeated failures to hold recent gains, with traders debating whether broader crypto weakness and persistent selling will continue to weigh on the token. Bulls point to Stellars institutional tokenization and payments developments, while skeptics argue that network adoption may not translate into meaningful XLM demand or price gains without changes to its token economics.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the Nov. 14 FDA decision on ivonescimab for EGFR-mutated lung cancer, with traders debating whether strong progression-free-survival results and AstraZenecas backing can offset the trials failure to meet formal overall-survival significance. The discussion is sharply divided between optimism about the drugs potential and concern that the FDA may reject the application over its stated survival-data requirements.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Traders are focused on whether Snowflakes consumption-based revenue can hold up if customers curb queries, shelve AI pilots, or cut data workloads amid budget pressure. Some see the recent bounce from support as a buying opportunity, while others expect usage growth to weaken; options activity reflects divided views.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubriks strong quarterly results and raised full-year outlook were followed by a sharp post-earnings selloff, prompting debate over profit-taking after a pre-report rally versus concerns about softer cloud net-new ARR growth and cautious second-half guidance. Bulls view the pullback as disconnected from solid execution, while bears argue expectations and valuation were too high.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

ABVX is drawing attention amid a sustained pullback despite positive Phase 3 data for obefazimod in ulcerative colitis. Traders debate whether the weakness reflects biotech-sector pressure and a wait for the NDA filing and Crohns data, while takeover hopes remain speculative.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toasts latest quarterly results are driving attention, with traders weighing stronger revenue growth and raised profit guidance against an EPS shortfall versus some estimates and plans for a CFO transition. The reaction is mixed: some see solid growth and a buying opportunity, while others criticize the stocks muted or negative response to the results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Above Food Ingredients, Inc. engages in operating its subsidiaries, Bite Acquisition Corp. (Bite) and Above Food Corp. (Above Food). The Bite is a blank check company that affects a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Above Food is an ingredient company that provides food products and brands. The company was founded by Lionel Kambeitz on April 18, 2023 and is headquartered in Regina, Canada.

Above Food Ingredients Inc.

Bearish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.042
Prev Close	$0.04
Open	$0.033
Dividend Yield	N/A
50-Day Moving Average	$0.0301
Beta	0.34
Avg. Volume	34,239.77
PE Ratio	N/A

52-Week High	$3.42
52-Week Low	$0.0001
Market Capitalization	$2.15M
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

ABVEF Fundamentals